Medifast provided earnings guidance for the first quarter of 2024. For the period, the company expects revenue to be in the range of $155 million to $175 million and diluted EPS to be in the range of $0.25 to $0.95.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.61 USD | -1.85% |
|
-5.36% | -70.83% |
Jun. 10 | KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24 | MT |
Jun. 05 | DA Davidson Downgrades Medifast to Underperform From Neutral With $17.50 Price Target | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.83% | 210M | |
+13.09% | 8.12B | |
+0.47% | 7.26B | |
-6.90% | 5.5B | |
-7.83% | 3.65B | |
-16.56% | 3.33B | |
-11.70% | 1.21B | |
-24.90% | 1.15B | |
+4.24% | 899M | |
-15.22% | 866M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast Provides Earnings Guidance for the First Quarter of 2024